131 Immunotherapy (2017) 9(2), 131–155 ISSN 1750-743X 10.2217/imt-2016-0091 © 2017 Future Medicine Ltd
A totally effective, antimalarial vaccine must involve sporozoite and merozoite
proteins (or their fragments) to ensure complete parasite blocking during critical
invasion stages. This Special Report examines proteins involved in critical biological
functions for parasite survival and highlights the conserved amino acid sequences
of the most important proteins involved in sporozoite invasion of hepatocytes and
merozoite invasion of red blood cells. Conserved high activity binding peptides are
located in such proteins’ functionally strategic sites, whose functions are related to
receptor binding, nutrient and protein transport, enzyme activity and molecule–
molecule interactions. They are thus excellent targets for vaccine development as they
block proteins binding function involved in invasion and also their biological function.
First draft submitted: 21 July 2016; Accepted for publication: 6 January 2017; Published
online: 27 January 2017
Keywords:cHABP•invasion-proteins•malaria•merozoite•sporozoite•vaccine
Malaria is one of the most prevalent infectious
diseases in the world; 3.2 billion of the world’s
population live in high-risk malarial areas, 214
million new cases and 438,000 deaths were
reported in 2015 [1] , caused by Plasmodium
parasites transmitted by an Anopheles mosquito
bite. Plasmodium falciparum is responsible for
the most severe cases and deaths [1] .
Important P. falciparum development
stages (sporozoite [Spz], liver stage, mero-
zoite [Mrz]) in the parasite’s life cycle in a
human host (summarized in Figure 1) could
be attacked to prevent its development and
affect the course of the disease, such stages
displaying a large set of stage-specific pro-
teins involved in binding, invasion, gliding
motility and adhesion [2–4] . Proteomic anal-
ysis has shown that around 30 proteins are
essential for Spz development and infectiv-
ity [5] and 50 more Mrz proteins are impli-
cated in invasion of erythrocytes or red blood
cells (RBCs) [6] .
A totally effective antimalarial vaccine must
involve Spz and Mrz proteins (or fragments) to
ensure complete parasite blocking during criti-
cal invasion stages for activating the two main
lines of defense against the parasite (humoral
and cell immunity) to obtain a fully protective
antimalarial vaccine capable of covering up to
95% of the world’s population.
Our endeavor, over the last 30 years, has
specifically involved studying the proteins
involved in vital processes for the parasite’s
development and growth, aimed at develop-
ing a complete fully protective minimal sub-
unit-based, chemically synthetized vaccine
against this deadly disease [7,8] .
A highly specific, sensitive and robust
receptor-ligand recognition methodology
was established a long time ago, involving
15–20 mer-long chemically synthetized pep-
tides spanning the protein’s entire sequence
to enable identifying high activity binding
peptides (HABPs), labeled according to our
Institute’s long-established serial numbering
system [2] .
Proteins involved in invasion of HepG2,
RBC and endothelial cell binding contain
Functionally relevant proteins in
Plasmodium falciparum host cell invasion
Manuel E Patarroyo
*,1,2
,
Martha P Alba
1,3
, Rocío Rojas-
Luna
1
, Adriana Bermudez
1,4
&
Jorge Aza-Conde
1
1
FundaciónInstitutodeInmunologíade
Colombia(FIDIC),Carrera50No.26–20
Bogotá,Colombia
2
UniversidadNacionaldeColombia,
BogotáDC,Colombia
3
UniversidaddeCienciasAplicadasy
Ambientales(UDCA),Bogotá,Colombia
4
UniversidaddelRosario,BogotáDC,
Colombia
*Authorforcorrespondence:
Tel:+5712225277
mepatarr@gmail.com
part of
Special Report
For reprint orders, please contact: reprints@futuremedicine.com